5/24/2023 2:00:00 PM ET
Indication
DAYBUE™ (trofinetide) is indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
Important Safety Information
Patients should stop taking laxatives before starting DAYBUE. If diarrhea occurs, patients should notify their healthcare provider, consider starting antidiarrheal treatment, and monitor hydration status and increase oral fluids, if needed. Interrupt, reduce dose, or discontinue DAYBUE if severe diarrhea occurs or if dehydration is suspected.
DAYBUE™ is available as an oral solution (200mg/mL).
Please read the accompanying full Prescribing Information, also available at DAYBUEHCP.com